Founded in 1964, the American Society of Clinical Oncology (ASCO) is the world’s leading professional organization that represents physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO’s efforts also are directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. ASCO has more than 40,000 members worldwide, with international members from more than 120 countries. The Society is led by President Daniel F. Hayes, MD, FACP, FASCO of the University of Michigan Comprehensive Cancer Center, and CEO Clifford A. Hudis, MD, FACP, FASCO.
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is the world’s leading non-profit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, healthcare professionals, government leaders and industry professionals from around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word "cure" a reality for cancer patients everywhere.